Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, March 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 199 articles:
HTML format


 

Single Articles

  1. ROCHA TA, Silva NC, Thomaz EB, Queiroz RC, et al
    Primary Health Care and Cervical Cancer Mortality Rates in Brazil: A Longitudinal Ecological Study.
    J Ambul Care Manage. 2017;40 Suppl 2 Supplement.
    Abstract    

    Abstract available

  2. XIA C, Chen R, Chen J, Qi Q, et al
    Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice.
    Sci Rep. 2017;7:43373.
    Abstract    

    Abstract available

  3. SHARMA A, Kulkarni V, Bhaskaran U, Singha M, et al
    Profile of cervical cancer patients attending Tertiary Care Hospitals of Mangalore, Karnataka: A 4 year retrospective study.
    J Nat Sci Biol Med. 2017;8:125-129.
    Abstract    

    Abstract available

  4. ELUFIOYE TO, Abdul AA, Moody JO
    Cytotoxicity Studies of the Extracts, Fractions, and Isolated Compound of Pseudocedrela kotschyi on Cervical Cancer (HeLa), Breast Cancer (MCF-7) and Skeletal Muscle Cancer (RD) Cells.
    Pharmacognosy Res. 2017;9:46-50.
    Abstract    

    Abstract available

  5. LI N, Zhang W
    Protein kinase C beta inhibits autophagy and sensitizes cervical cancer cells to cisplatin.
    Biosci Rep. 2017 Feb 28. pii: BSR20160445. doi: 10.1042/BSR20160445.
    Abstract    

    Abstract available

  6. QIAN S, Ye L, Tian YH, Wang LG, et al
    Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
    Chin J Cancer. 2017;36:24.
    Abstract    

    Abstract available

  7. LUO C, Qiu J
    MiR-181a Inhibits Cervical Cancer Development Via Downregulating GRP78.
    Oncol Res. 2017 Feb 13. doi: 10.3727/096504017X14867268787969.
    Abstract    

    Abstract available

  8. DAHIYA N, Bachani D, Acharya AS, Sharma DN, et al
    Socio-Demographic, Reproductive and Clinical Profile of Women Diagnosed with Advanced Cervical Cancer in a Tertiary Care Institute of Delhi.
    J Obstet Gynaecol India. 2017;67:53-60.
    Abstract    

    Abstract available

  9. BEYER S, Zhu J, Mayr D, Kuhn C, et al
    Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  10. CHEN Y, Wang CX, Sun XX, Wang C, et al
    Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:479-483.
    Abstract    

    Abstract available

  11. LIU Z, Li X, Tian S, Zhu T, et al
    Superiority of robotic surgery for cervical cancer in comparison with traditional Approaches: a systematic review and meta-analysis.
    Int J Surg. 2017 Feb 23. pii: S1743-9191(17)30187.
    Abstract    

    Abstract available

  12. TERUKINA J, Takamatsu M, Enomoto T, Baba H, et al
    Anesthetic management of abdominal radical trachelectomy for uterine cervical cancer during pregnancy.
    J Anesth. 2017 Feb 25. doi: 10.1007/s00540-017-2325.
    Abstract    

    Abstract available

  13. LIU J, Liu J, Guo SY, Liu HL, et al
    HSP70 inhibitor combined with cisplatin suppresses the cervical cancer proliferation in vitro and transplanted tumor growth: An experimental study.
    Asian Pac J Trop Med. 2017;10:184-188.
    Abstract    

    Abstract available

  14. DANG H, Zheng P, Liu Y, Wu X, et al
    MicroRNA-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1.
    Tumour Biol. 2017;39:1010428317691187.
    Abstract    

    Abstract available

  15. LEE H, Lee H, Cho YK
    Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
    Diagn Pathol. 2017;12:18.
    Abstract    

    Abstract available

  16. DAMIAO PA, Oliveira-Silva M, Moreira MA, Poliakova N, et al
    Human Papillomavirus types distribution among women with cervical preneoplastic, lesions and cancer in Luanda, Angola.
    Pan Afr Med J. 2016;24:268.
    Abstract    

    Abstract available

  17. EVANGELATOV A, Skrobanska R, Mladenov N, Petkova M, et al
    Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Drug Deliv. 2016;23:2235-2244.
    Abstract    

    Abstract available

  18. VAVROVA J, Zarybnicka L, Jost P, Tichy A, et al
    Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells.
    Folia Biol (Praha). 2016;62:167-74.
    Abstract    

    Abstract available

  19. GE TT, Yang M, Chen Z, Lou G, et al
    UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells.
    J Ovarian Res. 2016;9:42.
    Abstract    

    Abstract available

  20. ROMA AA
    Tubulosquamous polyps in the vagina. Immunohistochemical comparison with ectopic prostatic tissue and Skene glands.
    Ann Diagn Pathol. 2016;22:63-6.
    Abstract    

    Abstract available

  21. QIN T, Zhen J, Zhou M, Wu H, et al
    Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
    Int J Surg. 2016;30:121-5.
    Abstract    

    Abstract available

  22. JIN Y, Kim SC, Kim HJ, Ju W, et al
    Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix.
    Clin Chem Lab Med. 2016;54:1811-1819.
    Abstract    

    Abstract available

  23. DO SOCORRO NOBRE M, Jacyntho CM, Eleuterio J Jr, Giraldo PC, et al
    Abnormal anal cytology risk in women with known genital squamous intraepithelial lesion.
    Braz J Infect Dis. 2016;20:294-7.
    Abstract    

    Abstract available

  24. DUAN X, Ban X, Zhang X, Hu H, et al
    MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations.
    Eur Radiol. 2016;26:4293-4302.
    Abstract    

    Abstract available

  25. GOSWAMI L, Gogoi S, Gogoi J, Boruah RK, et al
    Facile Diversity-Oriented Synthesis of Polycyclic Pyridines and Their Cytotoxicity Effects in Human Cancer Cell Lines.
    ACS Comb Sci. 2016;18:253-61.
    Abstract    

    Abstract available

  26. XU Y, Yu J, Liu T, Meng F, et al
    Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
    Biomarkers. 2016;21:379-85.
    Abstract    

    Abstract available

  27. BIALKOWSKI L, van Weijnen A, Van der Jeught K, Renmans D, et al
    Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.
    Sci Rep. 2016;6:22509.
    Abstract    

    Abstract available

  28. JOURA E, Clark L, Luxembourg A
    Additional Protection from 9-Valent HPV Vaccine if Administered Before HPV Exposure.
    Am Fam Physician. 2016;93:254-6.
    Abstract    



  29. LIMA G, Santos E, Angelo H, Oliveira M, et al
    Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
    Tumour Biol. 2016;37:10935-41.
    Abstract    

    Abstract available

  30. KIM HJ, Moon BI, Lee JW, Kim SC, et al
    Age-related reduction of antibody response against the human endogenous retrovirus K envelope in women.
    Oncotarget. 2016;7:17327-37.
    Abstract    

    Abstract available

  31. ZHAO W, Wang H, Han X, Ma J, et al
    DeltaNp63alpha attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Tumour Biol. 2016;37:10621-32.
    Abstract    

    Abstract available

  32. PATEL H, Wilson E, Vizzotti C, Parston G, et al
    Argentina's Successful Implementation Of A National Human Papillomavirus Vaccination Program.
    Health Aff (Millwood). 2016;35:301-8.
    Abstract    

    Abstract available

  33. HERLIHY N, Hutubessy R, Jit M
    Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries.
    Health Aff (Millwood). 2016;35:227-34.
    Abstract    

    Abstract available

  34. VARGAS-TORRES SL, Portari EA, Silva AL, Klumb EM, et al
    Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia.
    Tumour Biol. 2016;37:10469-78.
    Abstract    

    Abstract available

  35. WANG F, Huang W, Hu X, Chen C, et al
    Transcription factor AP-2beta suppresses cervical cancer cell proliferation by promoting the degradation of its interaction partner beta-catenin.
    Mol Carcinog. 2017 Mar 9. doi: 10.1002/mc.22646.
    Abstract    

    Abstract available

  36. LIN TH, Hsu WH, Tsai PH, Huang YT, et al
    Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial-mesenchymal transition signaling.
    Food Funct. 2017 Mar 9. doi: 10.1039/c6fo00551.
    Abstract    

    Abstract available

  37. GRADISSIMO A, Burk RD
    Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.
    Expert Rev Mol Diagn. 2017 Feb 20:1-13. doi: 10.1080/14737159.2017.1293525.
    Abstract    

    Abstract available

  38. GAO YL, Zhao ZS, Zhang MY, Han LJ, et al
    Long Non-Coding RNA PVT1 Facilitates Cervical Cancer Progression Via Negative Regulating of miR-424.
    Oncol Res. 2017 Mar 8. doi: 10.3727/096504017X14881559833562.
    Abstract    

    Abstract available

  39. NAKISIGE C, Schwartz M, Ndira AO
    Cervical cancer screening and treatment in Uganda.
    Gynecol Oncol Rep. 2017;20:37-40.
    Abstract    

    Abstract available

  40. BARRA F, Lorusso D, Leone Roberti Maggiore U, Ditto A, et al
    Investigational drugs for the treatment of cervical cancer.
    Expert Opin Investig Drugs. 2017 Mar 8:1-14. doi: 10.1080/13543784.2017.1302427.
    Abstract    

    Abstract available

  41. YAGI A, Ueda Y, Egawa-Takata T, Tanaka Y, et al
    Realistic fear of cervical cancer risk in Japan depending on birth year.
    Hum Vaccin Immunother. 2017 Mar 8:0. doi: 10.1080/21645515.2017.1292190.
    Abstract    

    Abstract available

  42. LEE J, Lin JB, Sun FJ, Chen YJ, et al
    Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
    Medicine (Baltimore). 2017;96:e6158.
    Abstract    

    Abstract available

  43. OBIRI-YEBOAH D, Adu-Sarkodie Y, Djigma F, Akakpo K, et al
    Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.
    Gynecol Oncol Res Pract. 2017;4:5.
    Abstract    

    Abstract available

  44. JOUGLAR E, Thomas L, de la Rochefordiere A, Noel G, et al
    Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
    Cancer Radiother. 2016;20:794-800.
    Abstract    

    Abstract available

  45. RYAN HA, Neuber J, Shutong Song, Beebe SJ, et al
    Effects of a non-thermal plasma needle device on HPV-16 positive cervical cancer cell viability in vitro.
    Conf Proc IEEE Eng Med Biol Soc. 2016;2016:537-540.
    Abstract    

    Abstract available

  46. TILLY D, van de Schoot A, Grusell E, Bel A, et al
    Dose coverage calculation using a statistical shape model - applied to cervical cancer radiotherapy.
    Phys Med Biol. 2017 Mar 7. doi: 10.1088/1361-6560.
    Abstract    

    Abstract available

  47. WENTZENSEN N
    [Epidemiology, prevention and early detection of cervical cancer].
    Onkologe (Berl). 2016;22:725-736.
    Abstract    

    Abstract available

  48. KONTOSTATHI G, Zoidakis J, Makridakis M, Lygirou V, et al
    Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
    Biomed Res Int. 2017;2017:4180703.
    Abstract    

    Abstract available

  49. FENG Y, He F, Yan S, Huang H, et al
    The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer.
    J Cancer. 2017;8:443-454.
    Abstract    

    Abstract available

  50. XIONG H, Nie X, Zou Y, Gong C, et al
    Twist1 Enhances Hypoxia Induced Radioresistance in Cervical Cancer Cells by Promoting Nuclear EGFR Localization.
    J Cancer. 2017;8:345-353.
    Abstract    

    Abstract available

  51. WANG S, Meng X, Dong Y
    Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction.
    Int J Oncol. 2017 Feb 22. doi: 10.3892/ijo.2017.3890.
    Abstract    

    Abstract available

  52. DENG J, Zhang W, Liu S, An H, et al
    LATS1 suppresses proliferation and invasion of cervical cancer.
    Mol Med Rep. 2017 Feb 8. doi: 10.3892/mmr.2017.6180.
    Abstract    

    Abstract available

  53. KASHAFI E, Moradzadeh M, Mohamadkhani A, Erfanian S, et al
    Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways.
    Biomed Pharmacother. 2017;89:573-577.
    Abstract    

    Abstract available

  54. DAMATO AL, Buzurovic I, Bhagwat MS, Cormack RA, et al
    The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy.
    Brachytherapy. 2017 Feb 27. pii: S1538-4721(17)30014.
    Abstract    

    Abstract available

  55. HE D, Wang Z, Huang C, Fang X, et al
    Serum Selenium Levels and Cervical Cancer: Systematic Review and Meta-Analysis.
    Biol Trace Elem Res. 2017 Mar 2. doi: 10.1007/s12011-017-0982.
    Abstract    

    Abstract available

  56. GUCER F, Misirlioglu S, Ceydeli N, Taskiran C, et al
    Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    J Robot Surg. 2017 Mar 2. doi: 10.1007/s11701-017-0685.
    Abstract    

    Abstract available

  57. MARTINHO O, Silva-Oliveira R, Cury FP, Barbosa AM, et al
    HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors.
    Theranostics. 2017;7:717-732.
    Abstract    

    Abstract available

  58. FARZANEH E, Heydari H, Shekarchi AA, Kamran A, et al
    Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study.
    Onco Targets Ther. 2017;10:985-992.
    Abstract    

    Abstract available

  59. OKE-ALTUNTAS F, Ipekcioglu S, Sahin Yaglioglu A, Behcet L, et al
    Phytochemical analysis, antiproliferative and antioxidant activities of Chrozophora tinctoria: a natural dye plant.
    Pharm Biol. 2017;55:966-973.
    Abstract    

    Abstract available

  60. LI XS, Fang H, Song Y, Li D, et al
    The stratification of severity of acute radiation proctopathy after radiotherapy for cervical carcinoma using diffusion-weighted MRI.
    Eur J Radiol. 2017;87:105-110.
    Abstract    

    Abstract available

  61. AHMAD I, Chufal KS, Bhargava A, Bashir I, et al
    Primitive neuroectodermal tumour of the cervix: a rare diagnosis.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  62. TEOH PL, Cheng AY, Liau M, Lem FF, et al
    Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts.
    Pharm Biol. 2017;55:394-401.
    Abstract    

    Abstract available

  63. GUPTA M
    Malignant melanoma of cervix.
    BMJ Case Rep. 2016;2016.
    Abstract    

    Abstract available

  64. REGALO A, Caseiro L, Pereira E, Cortes J, et al
    Primary lymphoma of the uterine cervix: a rare constellation of symptoms.
    BMJ Case Rep. 2016;2016.
    Abstract    



  65. SANTOS C, Ferreirinha P, Sousa H, Ribeiro J, et al
    Ptaquiloside from bracken (Pteridium spp.) inhibits tumour-infiltrating CD8+ T cells in HPV-16 transgenic mice.
    Food Chem Toxicol. 2016;97:277-285.
    Abstract    

    Abstract available

  66. WILAILAK S, Lertchaipattanakul N
    The epidemiologic status of gynecologic cancer in Thailand.
    J Gynecol Oncol. 2016;27:e65.
    Abstract    

    Abstract available

  67. SUH DH, Kim M, Kim HJ, Lee KH, et al
    Major clinical research advances in gynecologic cancer in 2015.
    J Gynecol Oncol. 2016;27:e53.
    Abstract    

    Abstract available

  68. LIN MY, Kondalsamy-Chennakesavan S, Bernshaw D, Khaw P, et al
    Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes.
    J Gynecol Oncol. 2016;27:e59.
    Abstract    

    Abstract available

  69. SUNG YE, Ki EY, Lee YS, Hur SY, et al
    Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
    J Gynecol Oncol. 2016;27:e56.
    Abstract    

    Abstract available

  70. WEISS RA
    Tumour-inducing viruses.
    Br J Hosp Med (Lond). 2016;77:565-568.
    Abstract    

    Abstract available

  71. WRIGHT TC JR, Stoler MH, Aslam S, Behrens CM, et al
    Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.
    Am J Clin Pathol. 2016;146:391-8.
    Abstract    

    Abstract available

  72. KAWANO K, Tsuda N, Nishio S, Yonemoto K, et al
    Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia.
    J Gynecol Oncol. 2016;27:e54.
    Abstract    

    Abstract available

  73. MORTIER E, Doudeadoum N, Nemian F, Gaulier A, et al
    [Feasibility of cervical smear in HIV-positive women living in Chad].
    Bull Soc Pathol Exot. 2016;109:180-4.
    Abstract    

    Abstract available

  74. JIANG M, Lin X, He R, Lin X, et al
    Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.
    Med Sci Monit. 2016;22:1850-7.
    Abstract    

    Abstract available

  75. YANG J, Shen K, Wang J, Yang J, et al
    Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.
    J Gynecol Oncol. 2016;27:e40.
    Abstract    

    Abstract available

  76. PANDURANGAN M, Enkhtaivan G, Kim DH
    Anticancer studies of synthesized ZnO nanoparticles against human cervical carcinoma cells.
    J Photochem Photobiol B. 2016;158:206-11.
    Abstract    

    Abstract available

  77. ZHANG S, Xin J, Sun H, Ma J, et al
    Accuracy of PET/MR image coregistration of cervical lesions.
    Nucl Med Commun. 2016.
    Abstract    

    Abstract available

  78. YUE X, Zhao P, Wu K, Huang J, et al
    GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1alpha not STAT3 in Hela cells.
    Tumour Biol. 2016;37:9789-96.
    Abstract    

    Abstract available

  79. ZHOU H, Mody RR, Luna E, Armylagos D, et al
    Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Cancer Cytopathol. 2016;124:317-23.
    Abstract    

    Abstract available

  80. ISHIDA H, Tajima Y, Gonda T, Kumamoto K, et al
    Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan.
    Surg Today. 2016;46:1231-42.
    Abstract    

    Abstract available

  81. VINOTHKUMAR V, Arunkumar G, Revathidevi S, Arun K, et al
    TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Tumour Biol. 2016;37:7907-13.
    Abstract    

    Abstract available

  82. MINAMIMOTO R, Karam A, Jamali M, Barkhodari A, et al
    Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer.
    Eur J Nucl Med Mol Imaging. 2016;43:1047-55.
    Abstract    

    Abstract available

  83. KLOSKY JL, Favaro B, Peck KR, Simmons JL, et al
    Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.
    J Cancer Surviv. 2016;10:449-56.
    Abstract    

    Abstract available

  84. LEE DH, Hwang NR, Lim MC, Yoo CW, et al
    Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.
    Ann Clin Biochem. 2016;53.
    Abstract    

    Abstract available

  85. RAO YJ, Zoberi JE, Kadbi M, Grigsby PW, et al
    Metal artifact reduction in MRI-based cervical cancer intracavitary brachytherapy.
    Phys Med Biol. 2017;62:3011-3024.
    Abstract    

    Abstract available

  86. YUE Z, Yun-Shan Z, Feng-Xia X
    miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.
    J Renin Angiotensin Aldosterone Syst. 2016;17:1470320316663327.
    Abstract    

    Abstract available

  87. ZHANG R, Lu H, Lyu YY, Yang XM, et al
    E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.
    Sci Rep. 2017;7:44744.
    Abstract    

    Abstract available

  88. JALAGUIER-COUDRAY A, Villard-Mahjoub R, Delouche A, Delarbre B, et al
    Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Radiology. 2017 Mar 14:161299. doi: 10.1148/radiol.2017161299.
    Abstract    

    Abstract available

  89. ZHAO Y, Hang B, Xiong GW, Zhang XW, et al
    Laparoscopic Radical Hysterectomy in Early Stage Cervical Cancer: A Systematic Review and Meta-analysis.
    J Laparoendosc Adv Surg Tech A. 2017 Mar 16. doi: 10.1089/lap.2017.0022.
    Abstract    

    Abstract available

  90. BAHRAMI A, Hasanzadeh M, ShahidSales S, Yousefi Z, et al
    Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer.
    J Cell Biochem. 2017 Mar 16. doi: 10.1002/jcb.25992.
    Abstract    

    Abstract available

  91. OGBONNA FS
    Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University.
    Ann Afr Med. 2017;16:18-23.
    Abstract    

    Abstract available

  92. WAN B, Lang J, Wang P, Ma CM, et al
    Treatment optimization with concurrent SBRT and intracavitary brachytherapy for locally advanced cervical cancer.
    J Appl Clin Med Phys. 2016;17:70-79.
    Abstract    

    Abstract available

  93. FENG CH, Hasan Y, Kopec M, Al-Hallaq HA, et al
    Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer.
    J Appl Clin Med Phys. 2016;17:1-12.
    Abstract    

    Abstract available

  94. LEE B, Ahn SH, Kim H, Son J, et al
    Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
    J Appl Clin Med Phys. 2016;17:1-9.
    Abstract    

    Abstract available

  95. KIM Y, Modrick JM, Pennington EC, Kim Y, et al
    Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
    J Appl Clin Med Phys. 2016;17:405-426.
    Abstract    

    Abstract available

  96. GOYAL MK, Rai DV, Kehwar TS, Manjhi J, et al
    Anatomy-based definition of point A utilizing three-dimensional volumetric imaging approach for high-dose-rate (HDR) intracavitary brachytherapy dose prescription when treating cervical cancer using limited resources.
    J Appl Clin Med Phys. 2016;17:69-77.
    Abstract    

    Abstract available

  97. MEERSCHAERT R, Nalichowski A, Burmeister J, Paul A, et al
    A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    J Appl Clin Med Phys. 2016;17:323-333.
    Abstract    

    Abstract available

  98. CHANG L, Ho SY, Yeh SA, Lee TF, et al
    An innovative method to acquire the location of point A for cervical cancer treatment by HDR brachytherapy.
    J Appl Clin Med Phys. 2016;17:434-445.
    Abstract    

    Abstract available

  99. SHEN CJ, Cheng YM, Wang CL
    LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
    J Drug Target. 2017 Mar 15:1-19. doi: 10.1080/1061186X.2017.1307379.
    Abstract    

    Abstract available

  100. DENG X, Han C, Chen S, Xie C, et al
    Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
    J Appl Clin Med Phys. 2017;18:25-31.
    Abstract    

    Abstract available

  101. NDEJJO R, Mukama T, Musinguzi G, Halage AA, et al
    Women's intention to screen and willingness to vaccinate their daughters against cervical cancer - a cross sectional study in eastern Uganda.
    BMC Public Health. 2017;17:255.
    Abstract    

    Abstract available

  102. AL KHUDAIRI H, Abu-Zaid A, Alomar O, Salem H, et al
    Public Awareness and Knowledge of Pap Smear as a Screening Test for Cervical Cancer among Saudi Population in Riyadh City.
    Cureus. 2017;9:e984.
    Abstract    

    Abstract available

  103. HU Y, Xie H, Liu Y, Liu W, et al
    miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Cancer Cell Int. 2017;17:36.
    Abstract    

    Abstract available

  104. SHAFIEI-JANDAGHI NZ, Yavarian J, Faghihloo E, Ghavami N, et al
    Prevalence of adeno-associated virus and human papillomavirus DNA in Iranian women with and without cervical cancer.
    Pathol Res Pract. 2017 Feb 24. pii: S0344-0338(16)30364.
    Abstract    

    Abstract available

  105. IDEHEN EE, Korhonen T, Castaneda A, Juntunen T, et al
    Factors associated with cervical cancer screening participation among immigrants of Russian, Somali and Kurdish origin: a population-based study in Finland.
    BMC Womens Health. 2017;17:19.
    Abstract    

    Abstract available

  106. LIU L, Zhan P, Nie D, Fan L, et al
    Intermediate-Conductance-Ca2-Activated K Channel Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa1) is Upregulated and Promotes Cell Proliferation in Cervical Cancer.
    Med Sci Monit Basic Res. 2017;23:45-57.
    Abstract    

    Abstract available

  107. TAN SC, Ismail MP, Duski DR, Othman NH, et al
    FAS c.-671A>G polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Cancer Genet. 2017;211:18-25.
    Abstract    

    Abstract available

  108. TOTA JE, Bentley J, Blake J, Coutlee F, et al
    Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
    Prev Med. 2017;98:5-14.
    Abstract    

    Abstract available

  109. RODRIGUEZ AC, Salmeron J
    Cervical cancer prevention in upper middle-income countries.
    Prev Med. 2017;98:36-38.
    Abstract    

    Abstract available

  110. WENTZENSEN N, Arbyn M
    HPV-based cervical cancer screening- facts, fiction, and misperceptions.
    Prev Med. 2017;98:33-35.
    Abstract    

    Abstract available

  111. KINNEY WK, Huh WK
    Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
    Prev Med. 2017;98:31-32.
    Abstract    

    Abstract available

  112. SCHIFFMAN M
    Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.
    Prev Med. 2017;98:3-4.
    Abstract    



  113. TOTA JE, Bentley J, Blake J, Coutlee F, et al
    Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
    Prev Med. 2017;98:15-20.
    Abstract    

    Abstract available

  114. WHITE A, Thompson TD, White MC, Sabatino SA, et al
    Cancer Screening Test Use - United States, 2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
    Abstract    

    Abstract available

  115. ZHANG L, Niyazi HE, Zhao HR, Cao XP, et al
    Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.
    Genet Mol Res. 2017;16.
    Abstract    

    Abstract available

  116. KIM G, Cho H, Lee D, Park S, et al
    Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer.
    Exp Mol Pathol. 2017;102:321-326.
    Abstract    

    Abstract available

  117. BEN-ARYE E, Lavie O, Samuels N, Khamaisie H, et al
    Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a "bedside-to-bench" approach.
    Med Oncol. 2017;34:54.
    Abstract    

    Abstract available

  118. HE CY, Yang J
    miR-187 induces apoptosis of SiHa cervical carcinoma cells by downregulating Bcl-2.
    Genet Mol Res. 2017;16.
    Abstract    

    Abstract available

  119. XU W, Yu S, Ma Y, Liu C, et al
    Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Nucl Med Commun. 2017 Jan 21. doi: 10.1097/MNM.0000000000000641.
    Abstract    

    Abstract available

  120. TAGUCHI R, Higuchi K, Sudo M, Misawa K, et al
    A case of anaplastic lymphoma kinase (ALK)-positive ciliated muconodular papillary tumor (CMPT) of the lung.
    Pathol Int. 2017;67:99-104.
    Abstract    

    Abstract available

  121. IBRAHIM M, Kaushik N, Sowemimo A, Chhipa H, et al
    Antifungal and antiproliferative activities of endophytic fungi isolated from the leaves of Markhamia tomentosa.
    Pharm Biol. 2017;55:590-595.
    Abstract    

    Abstract available

  122. SORENSEN T, Andersen PT
    A qualitative study of women who experience side effects from human papillomavirus vaccination.
    Dan Med J. 2016;63.
    Abstract    

    Abstract available

  123. TSIAMBAS E, Riziotis C
    Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Pathol Int. 2017;67:24-31.
    Abstract    

    Abstract available

  124. SCARSBROOK A, Vaidyanathan S, Chowdhury F, Swift S, et al
    Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
    Eur J Nucl Med Mol Imaging. 2017;44:581-588.
    Abstract    

    Abstract available

  125. MEADOWS JL, Bichay TJ
    Low dose-rate brachytherapy for the treatment of cervix cancer is outdated and should be discontinued.
    Med Phys. 2016;43:4963.
    Abstract    



  126. LANDERS EE, Erickson BK, Bae S, Huh WK, et al
    Trends in Colposcopy Volume: Where Do We Go From Here?
    J Low Genit Tract Dis. 2016;20:292-5.
    Abstract    

    Abstract available

  127. KUROKI LM, James-Nywening L, Wu N, Liu J, et al
    High-Grade Cervical Dysplasia After Negative Loop Electrosurgical Excision Procedure.
    J Low Genit Tract Dis. 2016;20:300-6.
    Abstract    

    Abstract available

  128. UCAR MG, Ilhan TT, Ucar RM, Karabagli P, et al
    Diagnostic Value of Visual Examination of Cervical Polypoid Lesions and Predictors of Misdiagnosis.
    J Low Genit Tract Dis. 2016;20:356-9.
    Abstract    

    Abstract available

  129. SOARES LC, de Oliveira MA
    Cervical Adenocarcinoma: Are We Screening and Treating Patients Appropriately?
    J Low Genit Tract Dis. 2016;20:352-3.
    Abstract    



  130. DOO DW, Stickrath EH, Mazzoni SE, Alston MJ, et al
    Lack of Agreement Between Endocervical Brush and Endocervical Curettage in Women Undergoing Repeat Endocervical Sampling.
    J Low Genit Tract Dis. 2016;20:296-9.
    Abstract    

    Abstract available

  131. SYKES P, Innes C, Harker D, Whitehead M, et al
    Observational Management of CIN 2 in Young Women: A Prospective Multicenter Trial.
    J Low Genit Tract Dis. 2016;20:343-7.
    Abstract    

    Abstract available

  132. VOGEL WV, Bloemers MC, van der Heide UA, Beets-Tan RG, et al
    Accuracy of PET/MRI coregistration of cervical lesions.
    Nucl Med Commun. 2016;37:997-8.
    Abstract    



  133. BELINSON JL, Pretorius RG
    A Standard Protocol for the Colposcopy Exam.
    J Low Genit Tract Dis. 2016;20:e61-2.
    Abstract    



  134. BUSTILLOS D
    Political Pitfalls in Policymaking: The Texas HPV Vaccine Policy Saga.
    Narrat Inq Bioeth. 2016;6:6-10.
    Abstract    



  135. ZHANG HM, Chen SQ, Yao SZ
    Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
    Genet Mol Res. 2016;15.
    Abstract    

    Abstract available

  136. WANG XJ, Xiong Y, Ma ZB, Xia JC, et al
    The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
    Chin J Cancer. 2016;35:54.
    Abstract    

    Abstract available

  137. GAIO E, Scheglmann D, Reddi E, Moret F, et al
    Uptake and photo-toxicity of Foscan(R), Foslip(R) and Fospeg(R) in multicellular tumor spheroids.
    J Photochem Photobiol B. 2016;161:244-52.
    Abstract    

    Abstract available

  138. YANG DY, Bracken K
    Update on the new 9-valent vaccine for human papillomavirus prevention.
    Can Fam Physician. 2016;62:399-402.
    Abstract    

    Abstract available

  139. VORSTERS A, Van Keer S, Biesmans S, Hens A, et al
    Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing.
    Int J Mol Sci. 2016;17.
    Abstract    

    Abstract available

  140. LASZLO B, Ferenczi A, Madar L, Gyongyosi E, et al
    CpG methylation in human papillomavirus (HPV) type 31 long control region (LCR) in cervical infections associated with cytological abnormalities.
    Virus Genes. 2016;52:552-5.
    Abstract    

    Abstract available

  141. QUDJANI E, Iman M, Davood A, Ramandi MF, et al
    Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
    Recent Pat Anticancer Drug Discov. 2016;11:342-51.
    Abstract    

    Abstract available

  142. SUN L, Xia WY, Zhao SH, Liu N, et al
    An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
    Int J Oncol. 2016;48:2461-71.
    Abstract    

    Abstract available

  143. MAO C, Kulasingam SL, Whitham HK, Hawes SE, et al
    Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.
    J Womens Health (Larchmt). 2017 Mar 23. doi: 10.1089/jwh.2016.5965.
    Abstract    

    Abstract available

  144. ROMAN-JIMENEZ G, Acosta O, Leseur J, Devillers A, et al
    Random forests to predict tumor recurrence following cervical cancer therapy using pre- and per-treatment 18F-FDG PET parameters.
    Conf Proc IEEE Eng Med Biol Soc. 2016;2016:2444-2447.
    Abstract    

    Abstract available

  145. VAJDA R, Arvane Egri C, Kovacs A, Budai A, et al
    [Assessment of the pilot program for cervical cancer screening by health visitors].
    Orv Hetil. 2017;158:461-467.
    Abstract    

    Abstract available

  146. JIN F, Luo HL, Zhou J, Yang DY, et al
    A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer.
    Sci Rep. 2017;7:280.
    Abstract    

    Abstract available

  147. MORENO-ACOSTA P, Vallard A, Molano M, Huertas A, et al
    HPV-16 variants' impact on uterine cervical cancer response to radiotherapy: A descriptive pilot study.
    Cancer Radiother. 2017 Mar 18. pii: S1278-3218(17)30041.
    Abstract    

    Abstract available

  148. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    Abstract    

    Abstract available

  149. PRATT R, Mohamed S, Dirie W, Ahmed N, et al
    Views of Somali women and men on the use of faith-based messages promoting breast and cervical cancer screening for Somali women: a focus-group study.
    BMC Public Health. 2017;17:270.
    Abstract    

    Abstract available

  150. SCHOB S, Meyer HJ, Pazaitis N, Schramm D, et al
    ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.
    Mol Imaging Biol. 2017 Mar 17. doi: 10.1007/s11307-017-1073.
    Abstract    

    Abstract available

  151. THANTHONG S, Rojthamarat S, Worasawate W, Vichitvejpaisal P, et al
    Comparison of efficacy of meperidine and fentanyl in terms of pain management and quality of life in patients with cervical cancer receiving intracavitary brachytherapy: a double-blind, randomized controlled trial.
    Support Care Cancer. 2017 Mar 18. doi: 10.1007/s00520-017-3662.
    Abstract    

    Abstract available

  152. GADDUCCI A, Barsotti C, Laliscia C, Cosio S, et al
    Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis.
    Anticancer Res. 2017;37:1249-1255.
    Abstract    

    Abstract available

  153. TAN SC, Ismail MP, Duski DR, Othman NH, et al
    Identification of Optimal Reference Genes for Normalization of RT-qPCR Data in Cancerous and Non-Cancerous Tissues of Human Uterine Cervix.
    Cancer Invest. 2017;35:163-173.
    Abstract    

    Abstract available

  154. CHERIAN RM, Jeba J, Mukhopadhyay S, Backianathan S, et al
    Unusual sites of metastases of carcinoma cervix.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  155. CREMER M, Maza M, Alfaro K, Morales Velado M, et al
    Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
    J Low Genit Tract Dis. 2017;21:26-32.
    Abstract    

    Abstract available

  156. LISS J, Alston M, Krull MB, Mazzoni SE, et al
    Predictors of Positive Margins at Time of Loop Electrosurgical Excision Procedure.
    J Low Genit Tract Dis. 2017;21:64-66.
    Abstract    

    Abstract available

  157. RANGA R, Rai S, Kumari A, Mathur S, et al
    A Comparison of the Strength of Association of Reid Colposcopic Index and Swede Score With Cervical Histology.
    J Low Genit Tract Dis. 2017;21:55-58.
    Abstract    

    Abstract available

  158. CEJTIN HE, Zimmerman L, Mathews M, Patel A, et al
    Predictors of Persistent or Recurrent Disease After Loop Electrosurgical Excision Procedure.
    J Low Genit Tract Dis. 2017;21:59-63.
    Abstract    

    Abstract available

  159. LIM KH, Tay SK, Ng AX, Mantoo S, et al
    Primary Melanoma of the Uterine Cervix: A Case Report, With Key Points on Recognition and Pathological Diagnosis.
    J Low Genit Tract Dis. 2017;21:e1-e4.
    Abstract    



  160. RAVAIOLI S, Tumedei MM, Amadori A, Puccetti M, et al
    Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization.
    J Low Genit Tract Dis. 2017;21:42-46.
    Abstract    

    Abstract available

  161. KYRGIOU M, Athanasiou A, Paraskevaidi M, Mitra A, et al
    Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.
    BMJ. 2016;354:i3633.
    Abstract    

    Abstract available

  162. LEVY RA, Kumarapeli AR, Spencer HJ, Quick CM, et al
    Cervical polyps: Is histologic evaluation necessary?
    Pathol Res Pract. 2016;212:800-3.
    Abstract    

    Abstract available

  163. ZHAO H, Shao H
    [Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41:606-11.
    Abstract    

    Abstract available

  164. LARGERON N, Petry KU, Jacob J, Bianic F, et al
    An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.
    Expert Rev Pharmacoecon Outcomes Res. 2017;17:85-98.
    Abstract    

    Abstract available

  165. MYRIOKEFALITAKI E, Redman CW, Potdar N, Pearmain P, et al
    The Use of the Colposcopically Directed Punch Biopsy in Clinical Practice: A Survey of British Society of Colposcopy and Cervical Pathology (BSCCP)-Accredited Colposcopists.
    J Low Genit Tract Dis. 2016;20:234-8.
    Abstract    

    Abstract available

  166. SMITH HJ, Leath CA 3rd, Huh WK, Erickson BK, et al
    See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?
    J Low Genit Tract Dis. 2016;20:243-6.
    Abstract    

    Abstract available

  167. KUROKI LM, Bergeron LM, Gao F, Thaker PH, et al
    See-and-Treat Loop Electrosurgical Excision Procedure for High-Grade Cervical Cytology: Are We Overtreating?
    J Low Genit Tract Dis. 2016;20:247-51.
    Abstract    

    Abstract available

  168. MADELEINE MM, Johnson LG, Doody DR, Tipton ER, et al
    Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).
    J Low Genit Tract Dis. 2016;20:257-60.
    Abstract    

    Abstract available

  169. ANDREWS JC, Lawson HW
    The Role of the Male in Preventing HPV-Related Diseases.
    J Low Genit Tract Dis. 2016;20:195-6.
    Abstract    



  170. LOOPIK DL, Doucette S, Bekkers RL, Bentley JR, et al
    Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years.
    J Low Genit Tract Dis. 2016;20:213-7.
    Abstract    

    Abstract available

  171. JAYASINGHE YL, Bhat R, Quinn M, Wrede CD, et al
    Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service.
    J Low Genit Tract Dis. 2016;20:224-9.
    Abstract    

    Abstract available

  172. POLICIANO AC, Lopes JP, Barata SA, Colaco AM, et al
    Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series.
    J Low Genit Tract Dis. 2016;20:e34-6.
    Abstract    



  173. SZENDER JB, Cannioto R, Gulati NR, Schmitt KL, et al
    Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study.
    J Low Genit Tract Dis. 2016;20:230-3.
    Abstract    

    Abstract available

  174. KUDELA E, Biringer K, Kasajova P, Nachajova M, et al
    Perivascular epithelioid cell tumors of the uterine cervix.
    Pathol Res Pract. 2016;212:667-71.
    Abstract    

    Abstract available

  175. BUSCA A, Parra-Herran C
    Hemangiomas of the uterine cervix: Association with abnormal bleeding and pain in young women and hormone receptor expression. Report of four cases and review of the literature.
    Pathol Res Pract. 2016;212:532-8.
    Abstract    

    Abstract available

  176. WHOP LJ, Garvey G, Baade P, Cunningham J, et al
    The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
    Cancer. 2016;122:1560-9.
    Abstract    

    Abstract available

  177. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    Abstract    

    Abstract available

  178. ARMSTRONG K, Kim JJ, Halm EA, Ballard RM, et al
    Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Cancer. 2016 Feb 29. doi: 10.1002/cncr.29937.
    Abstract    

    Abstract available

  179. DUDDING N
    Cytology training in the UK: a training centre prospective.
    Cytopathology. 2016;27:321-4.
    Abstract    

    Abstract available

  180. LATSUZBAIA A, Hebette G, Fischer M, Arbyn M, et al
    Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in luxembourg.
    Diagn Cytopathol. 2017 Mar 1. doi: 10.1002/dc.23678.
    Abstract    

    Abstract available

  181. RATHORE R, Arora VK, Singh B
    Lymphoepithelioma-like carcinoma of cervix: Cytological Features on Conventional Cervical Smear.
    Diagn Cytopathol. 2017;45:239-242.
    Abstract    

    Abstract available

  182. YANG G, Deisch J, Tavares M, Haixia Q, et al
    Primary B-cell lymphoma of the uterine cervix: Presentation in Pap-test slide and cervical biopsy.
    Diagn Cytopathol. 2016 Nov 8. doi: 10.1002/dc.23627.
    Abstract    

    Abstract available

  183. SHERMAN SM, Moss EL, Pearmain P, Redman CW, et al
    Colposcopists' experiences of HPV Test of Cure for the follow up of cervical intra-epithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:42-5.
    Abstract    

    Abstract available

  184. AYHAN A, Tuncer HA, Reyhan NH, Kuscu E, et al
    Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:1-6.
    Abstract    

    Abstract available

  185. RING KL, Yemelyanova AV, Soliman PT, Frumovitz MM, et al
    Potential immunotherapy targets in recurrent cervical cancer.
    Gynecol Oncol. 2017 Feb 20. pii: S0090-8258(17)30148.
    Abstract    

    Abstract available

  186. WANG YM, Wang CJ, Fang FM, Chen HC, et al
    Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study.
    Gynecol Oncol. 2017 Mar 5. pii: S0090-8258(17)30155.
    Abstract    

    Abstract available

  187. DAS GHOSH D, Mukhopadhyay I, Bhattacharya A, Roy Chowdhury R, et al
    Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30681.
    Abstract    

    Abstract available

  188. MEZEI AK, Armstrong HL, Pedersen HN, Campos NG, et al
    Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review.
    Int J Cancer. 2017 Mar 15. doi: 10.1002/ijc.30695.
    Abstract    

    Abstract available

  189. LIU ZS, Guo J, Zhao YZ, Lin X, et al
    Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Int J Gynecol Cancer. 2017 Mar 6. doi: 10.1097/IGC.0000000000000929.
    Abstract    

    Abstract available

  190. LEE JW, Jeon S, Mun ST, Lee SM, et al
    Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000949.
    Abstract    

    Abstract available

  191. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:797-805.
    Abstract    

    Abstract available

  192. RAMLOV A, Pedersen EM, Rohl L, Worm E, et al
    Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:1032-1039.
    Abstract    

    Abstract available

  193. HAN S, Li Y, Zhang J, Liu L, et al
    Roles of immune inhibitory molecule B7-H4 in cervical cancer.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5481.
    Abstract    

    Abstract available

  194. YIN Z, Sun Y, Ge S, Sun J, et al
    Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5463.
    Abstract    

    Abstract available

  195. YIN F, Wang N, Wang S, Yu F, et al
    HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5465.
    Abstract    

    Abstract available

  196. PEI Z, Zeng J, Gao Y, Li F, et al
    Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression.
    Oncol Rep. 2016;36:291-8.
    Abstract    

    Abstract available

  197. ZHANG X, Cai D, Meng L, Wang B, et al
    MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Oncol Rep. 2016;36:2321-8.
    Abstract    

    Abstract available

  198. YAMAZAKI H, Nakamura S, Suzuki G, Yoshida K, et al
    Comment on "Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer" Kari Tanderup et al.
    Radiother Oncol. 2017 Feb 22. pii: S0167-8140(17)30067.
    Abstract    



  199. YOO W, Kim S, Huh WK, Dilley S, et al
    Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
    PLoS One. 2017;12:e0172548.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;